Back to Results
First PageMeta Content
Immunosuppressants / Orphan drugs / Amides / Bortezomib / Pyrazines / Lenalidomide / Multiple myeloma / Dexamethasone / Mantle cell lymphoma / Medicine / Chemistry / Organic chemistry


ASCO[removed]Clinical response by baseline characteristics in patients with relapsed and bortezomib-refractory multiple myeloma treated with panobinostat, bortezomib, and dexamethasone (PANORAMA 2) Melissa Alsina,1 Paul G.
Add to Reading List

Document Date: 2013-06-10 19:40:25


Open Document

File Size: 408,41 KB

Share Result on Facebook
UPDATE